A Call to Arms for Open Innovation
Author: Dave Neundorfer Dec 1, 2020 – 5 min read Last month, I shared with you a guide to quality control in CBD 3.0, where we discussed the technological advancements and testing methods necessary to ensure the integrity and consistency of your supply chain and...
Your Guide To Quality Control In CBD 3.0
Author: Dave Neundorfer Nov 3, 2020 – 8 min read Over the past few months, we’ve shared our perspective on what the cannabinoid industry needs to graduate from a nascent, $1B industry into the mainstream, cross-category, $20B+ powerhouse that analysts have...
Why September Was An Explosive Month for Mainstream CPGs and CBD
Author: Dave Neundorfer September 30, 2020 – 5 min read Martha, Gronk, and Playboy–cultural icons brought together by their full-throated endorsements of CBD as part of a continuing trend of big brands and businesses entering the space. This trifecta of...
Are Your Products Ready For CBD 3.0?
Author: Nicole Brown, CCO Over the past few months, we’ve shared our future perspective on the industry as we climb to CBD 3.0 — the need for research, the therapeutic promise of minor cannabinoids, the flight to quality that brands and the “buyers of tomorrow”...
The Regulatory Barbell Problem
Author: Dave Neundorfer, CEO As everyone knows, the FDA is yet to create a clear legal framework for the use of cannabinoids in dietary supplements, food and beverage products. This has created a regulatory barbell effect in the market, with the “Wild West” on one...Page 4 of 5